The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses (Q39455183)

12 September 2017

title

The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses (English)

1 reference

12 September 2017

1 reference

1 reference

O Terrier

0 references

F Durupt

1 reference

12 September 2017

D Koppers-Lalic

1 reference

12 September 2017

B Balme

1 reference

12 September 2017

L Budel

1 reference

12 September 2017

B Lina

1 reference

12 September 2017

L Thomas

1 reference

12 September 2017

R C Hoeben

1 reference

12 September 2017

M Rosa-Calatrava

1 reference

12 September 2017

publication date

21 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

58-68

1 reference

Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

In vivo models of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Accessing key steps of human tumor progression in vivo by using an avian embryo model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

A novel and rapid in vivo system for testing therapeutics on human leukemias

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

A chick embryo model for metastatic human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Multicellular tumor spheroids: an underestimated tool is catching up again.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Establishment of human tumor xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

A three-dimensional assay for measurement of viral-induced oncolysis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Antiangiogenesis gene armed tumor-targeting adenovirus yields multiple antitumor activities in human HCC xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.68

7 January 2021

Identifiers

DOI

10.1038/CGT.2011.68

1 reference

12 September 2017

1 reference